Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Share-based Compensation (2023 - 2025)

Cardio Diagnostics Holdings' Share-based Compensation history spans 3 years, with the latest figure at $24762.0 for Q3 2025.

  • For Q3 2025, Share-based Compensation rose 9.48% year-over-year to $24762.0; the TTM value through Sep 2025 reached $108567.0, down 95.87%, while the annual FY2024 figure was $2.6 million, 102.55% up from the prior year.
  • Share-based Compensation for Q3 2025 was $24762.0 at Cardio Diagnostics Holdings, down from $30778.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $2.5 million in Q1 2024 and bottomed at $4000.0 in Q1 2023.
  • The 3-year median for Share-based Compensation is $30612.0 (2025), against an average of $359690.3.
  • The largest annual shift saw Share-based Compensation surged 62885.1% in 2024 before it tumbled 98.78% in 2025.
  • A 3-year view of Share-based Compensation shows it stood at $62000.0 in 2023, then plummeted by 63.85% to $22415.0 in 2024, then increased by 10.47% to $24762.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Share-based Compensation are $24762.0 (Q3 2025), $30778.0 (Q2 2025), and $30612.0 (Q1 2025).